journal
Journals Clinical and Experimental Neph...

Clinical and Experimental Nephrology

https://read.qxmd.com/read/38954310/albuminuria-and-chronic-kidney-disease-progression-in-patients-with-type-2-diabetes-mellitus
#21
LETTER
Tomoyuki Kawada
No abstract text is available yet for this article.
July 2, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38954309/usefulness-of-16s-rrna-gene-analysis-for-peritoneal-associated-peritonitis-a-single-center-cohort-study
#22
LETTER
Sumie Sakamoto, Tomohiko Inoue, Rina Tanaka, Hideaki Aihara, Tomo Suzuki
No abstract text is available yet for this article.
July 2, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38954308/association-between-serum-magnesium-levels-and-cognitive-function-in-patients-undergoing-hemodialysis
#23
JOURNAL ARTICLE
Kazuhiko Kato, Akio Nakashima, Shunichiro Shinagawa, Arisa Kobayashi, Ichiro Ohkido, Mitsuyoshi Urashima, Takashi Yokoo
BACKGROUND: The relationship between chronic kidney disease-mineral and bone disorder (CKD-MBD) and cognitive function remains largely unknown. This cross-sectional study aimed to explore the association between CKD-MBD and cognitive function in patients on hemodialysis. METHODS: Hemodialysis patients aged ≥ 65 years without diagnosed dementia were included. Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE)...
July 2, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38935212/protective-effects-of-pioglitazone-in-renal-ischemia-reperfusion-injury-riri-focus-on-oxidative-stress-and-inflammation
#24
REVIEW
Maryam Golmohammadi, Mehraveh Sadeghi Ivraghi, Ekhlas Khammas Hasan, Huldani Huldani, Mohammad Yasin Zamanian, Shiva Rouzbahani, Yasser Fakri Mustafa, Shaker Shanawa Al-Hasnawi, Adeeb Abdulally Abdulhussien Alazbjee, Faranak Khalajimoqim, Fattaneh Khalaj
BACKGROUND: Renal ischemia-reperfusion injury (RIRI) is a critical phenomenon that compromises renal function and is the most serious health concern related to acute kidney injury (AKI). Pioglitazone (Pio) is a known agonist of peroxisome proliferator-activated receptor-gamma (PPAR-γ). PPAR-γ is a nuclear receptor that regulates genes involved in inflammation, metabolism, and cellular differentiation. Activation of PPAR-γ is associated with antiinflammatory and antioxidant effects, which are relevant to the pathophysiology of RIRI...
June 27, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38914914/correction-to-ability-of-nad-and-sirt1-to-epigenetically-suppress-albuminuria
#25
Kazuhiro Hasegawa, Masanori Tamaki, Eriko Shibata, Taizo Inagaki, Masanori Minato, Sumiyo Yamaguchi, Ikuko Shimizu, Shinji Miyakami, Miho Tada, Shu Wakino
No abstract text is available yet for this article.
June 25, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38914913/peritoneal-dialysis-related-infections-in-elderly-patients
#26
REVIEW
Tsutomu Sakurada, Masanobu Miyazaki, Masaaki Nakayama, Yasuhiko Ito
This review outlines the epidemiology, characteristics, risk factors, and prognosis of peritoneal dialysis (PD)-related peritonitis, PD catheter-related infections, and the effects of assisted PD in elderly patients from the Japanese perspective. Based on the literature, the incidence of peritonitis is likely to be higher in elderly patients than in younger patients. The most frequent causative bacteria in elderly patients are Gram-positive bacteria, as in adult PD patients, most commonly due to transcatheter infection...
June 25, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38914912/estimating-baseline-creatinine-levels-based-on-the-kidney-parenchymal-volume
#27
JOURNAL ARTICLE
Takaya Sasaki, Takeshi Tosaki, Hideaki Kuno, Hirokazu Marumoto, Yusuke Okabayashi, Kotaro Haruhara, Go Kanzaki, Kentaro Koike, Akimitsu Kobayashi, Izumi Yamamoto, Nobuo Tsuboi, Takashi Yokoo
BACKGROUND: Acute kidney injury (AKI) diagnosis often lacks a baseline serum creatinine (Cr) value. Our study aimed to create a regression equation linking kidney morphology to function in kidney donors and chronic kidney disease patients. We also sought to estimate baseline Cr in minimal change disease (MCD) patients, a common AKI-predisposing condition. METHODS: We analyzed 119 participants (mean age 60 years, 50% male, 40% donors) with CT scans, dividing them into derivation and validation groups...
June 25, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38914911/barriers-to-conservative-kidney-management-for-japanese-healthcare-professionals-involved-in-the-treatment-of-end-stage-renal-disease
#28
JOURNAL ARTICLE
Yumi Sota, Takuya Fujimaru, Kyoko Kobayashi, Kevin Y Urayama, Nozomi Kadota, Kasumi Konishi, Yugo Ito, Masahiko Nagahama, Fumika Taki, Michiko Suzuki, Masaaki Nakayama
BACKGROUND: Conservative kidney management (CKM) is a treatment alternative for patients with end-stage kidney disease (ESKD). Despite the increasing population of elderly dialysis patients in Japan, CKM is not as readily available compared with that in North America and Europe. Therefore, it is important to clarify the barriers to CKM in Japan. METHODS: We interviewed 11 experts to explore their beliefs and issues regarding CKM. Based on the interviews, we categorized the CKM barriers into eight categories and created a 24-item questionnaire...
June 25, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38888720/a-comparison-of-the-clinical-efficacy-of-tonsillectomy-with-steroid-pulse-therapy-and-tonsillectomy-therapy-alone-for-patients-with-immunoglobulin-a-nephropathy-a-retrospective-observational-study
#29
JOURNAL ARTICLE
Ryosuke Sato, Risa Wakisaka, Hiroki Komatsuda, Hidekiyo Yamaki, Kenzo Ohara, Takumi Kumai, Kan Kishibe, Naoki Nakagawa, Tatsuya Hayashi, Miki Takahara
BACKGROUND: Tonsillectomy with steroid pulse therapy (TSP) and tonsillectomy monotherapy (T) have improved the prognosis of patients with immunoglobulin A nephropathy (IgAN). However, a consensus has not been reached on the best treatment for these patients. This study aimed to compare the efficacies of TSP and T. METHODS: Data of patients with IgAN who received TSP or T were retrospectively analyzed. The exclusion criterion was a serum creatinine level > 1...
June 18, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38879735/adverse-reactions-and-effects-on-renal-function-of-covid-19-vaccines-in-patients-with-iga-nephropathy
#30
JOURNAL ARTICLE
Katsushi Nagatsuji, Takashi Morikawa, Natsuki Ide, Ryuichi Kunishige, Shiho Takahata, Aoi Matsuki, Keita Kadosawa, Yuko Sakata, Daisuke Yamazaki, Mikiko Shibata, Masahiro Hamada, Chizuko Kitabayashi, Akira Nishiyama, Yoshio Konishi
BACKGROUND: Although vaccination has been reported to reduce the morbidity and severity of COVID-19 infection in patients with kidney disease, gross hematuria is frequently reported following vaccination in patients with IgA nephropathy. We investigated the frequency of gross hematuria following COVID-19 vaccination and its effect on renal function in IgA nephropathy patients. METHODS: Adverse reactions after two or more COVID-19 vaccine doses were investigated in 295 IgA nephropathy patients attending Osaka Cty general hospital from September 2021 to November 2022...
June 15, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38877226/evaluation-of-pathogenicity-of-wt1-intron-variants-by-in-vitro-splicing-analysis
#31
JOURNAL ARTICLE
Seiya Inoue, Atsushi Kondo, Yuta Inoki, Yuta Ichikawa, Yu Tanaka, Chika Ueda, Hideaki Kitakado, Ryota Suzuki, Eri Okada, Nana Sakakibara, Tomoko Horinouchi, Kandai Nozu
BACKGROUND: Wilms tumor 1 (WT1; NM_024426) causes Denys-Drash syndrome, Frasier syndrome, or isolated focal segmental glomerulosclerosis. Several WT1 intron variants are pathogenic; however, the pathogenicity of some variants remains undefined. Whether a candidate variant detected in a patient is pathogenic is very important for determining the therapeutic options for the patient. METHODS: In this study, we evaluated the pathogenicity of WT1 gene intron variants with undetermined pathogenicity by comparing their splicing patterns with those of the wild-type using an in vitro splicing assay using minigenes...
June 14, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38970650/guidelines-for-clinical-evaluation-of-chronic-kidney-disease-in-early-stages-amed-research-on-regulatory-science-of-pharmaceuticals-and-medical-devices
#32
JOURNAL ARTICLE
Yuka Sugawara, Eiichiro Kanda, Takayuki Hamano, Seiji Itano, Hirokazu Okada, Koji Tomori, Yusuke Watanabe, Wataru Asakura, Yoshitaka Isaka, Kunitoshi Iseki, Tomoko Usui, Yusuke Suzuki, Mototsugu Tanaka, Rimei Nishimura, Kei Fukami, Kunihiro Matsushita, Jun Wada, Hirotaka Watada, Kohjiro Ueki, Naoki Kashihara, Masaomi Nangaku
BACKGROUND: For the development of pharmaceutical products in kidney field, appropriate surrogate endpoints which can predict long-term prognosis are needed as an alternative to hard endpoints, such as end-stage kidney disease. Though international workshop has proposed estimated glomerular filtration rate (GFR) slope reduction of 0.5-1.0 mL/min/1.73 m /year and 30% decrease in albuminuria/proteinuria as surrogate endpoints in early and advanced chronic kidney disease (CKD), it was not clear whether these are applicable to Japanese patients...
September 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38530491/multicenter-randomized-controlled-trial-of-intensive-uric-acid-lowering-therapy-for-ckd-patients-with-hyperuricemia-target-ua
#33
RANDOMIZED CONTROLLED TRIAL
Tetsuya Yamamoto, Masato Kasahara, Kenji Ueshima, Shiro Uemura, Naoki Kashihara, Kenjiro Kimura, Tsuneo Konta, Tetsuo Shoji, Akira Mima, Masashi Mukoyama, Yoshihiko Saito
BACKGROUND: We investigate whether Intensive uric acid (UA)-lowering therapy (ULT) provides increased renal protection compared with standard therapy in chronic kidney disease (CKD) patients. METHODS: This was a multicenter randomized controlled trial. Only CKD patients with hyperuricemia were included in this study. The participants were randomly assigned to either the Intensive therapy group (target serum UA level ≥ 4.0 mg/dL and < 5...
August 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38240879/prevalence-and-prognosis-of-severe-hyperkalemia-in-the-emergency-department
#34
LETTER
Teppei Koyama, Kita Youhei, Ryuichiro Makinouchi, Shinji Machida, Naohiko Imai
No abstract text is available yet for this article.
July 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38872014/oral-alkalinizing-supplementation-suppressed-intrarenal-reactive-oxidative-stress-in-mild-stage-chronic-kidney-disease-a-randomized-cohort-study
#35
JOURNAL ARTICLE
Michiaki Abe, Takuhiro Yamaguchi, Seizo Koshiba, Shin Takayama, Toshiki Nakai, Koichiro Nishioka, Satomi Yamasaki, Kazuhiko Kawaguchi, Masanori Umeyama, Atsuko Masaura, Kota Ishizawa, Ryutaro Arita, Takeshi Kanno, Tetsuya Akaishi, Mariko Miyazaki, Takaaki Abe, Tetsuhiro Tanaka, Tadashi Ishii
BACKGROUND: The beneficial effects of oral supplements with alkalinizing agents in patients with chronic kidney disease (CKD) have been limited to the severe stages. We investigated whether two types of supplements, sodium bicarbonate (SB) and potassium citrate/sodium citrate (PCSC), could maintain renal function in patients with mild-stage CKD. METHODS: This was a single-center, open-labeled, randomized cohort trial. Study participants with CKD stages G2, G3a, and G3b were enrolled between March 2013 and January 2019 and randomly assigned by stratification according to age, sex, estimated glomerular filtration rate (eGFR), and diabetes...
June 13, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38851645/prognosis-of-microscopic-polyangiitis-is-well-predictable-in-the-first-2-weeks-of-treatment
#36
JOURNAL ARTICLE
Akiko Owaki, Akihito Tanaka, Kazuhiro Furuhashi, Yu Watanabe, Eri Koshi-Ito, Takahiro Imaizumi, Shoichi Maruyama
BACKGROUND: Kidney and life outcomes remain unsatisfactory in patients with microscopic polyangiitis (MPA). Appropriate treatment intensity must be provided to the appropriate patients. To identify severe cases early, we investigated the factors related to kidney and life outcomes. METHODS: We included patients diagnosed with MPA based on myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) positivity and kidney histopathology results after kidney biopsies between January 1, 2021, and May 11, 2023, at 10 affiliated centers, including our hospital...
June 8, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38831157/relapse-during-and-after-regular-single-dose-rituximab-treatment-in-adult-patients-with-steroid-dependent-nephrotic-syndrome
#37
JOURNAL ARTICLE
Eiichiro Saito, Atsushi Oura, Tetsuya Kyo, Shun Ishigaki, Hitomi Kamei, Yuki Nakamura, Jun Soma, Izaya Nakaya
BACKGROUND: Rituximab is widely used in patients with steroid-dependent nephrotic syndrome. However, information on the effect of long-term rituximab treatment is limited. This study examined the efficacy of rituximab during and after treatment in adult patients with steroid-dependent nephrotic syndrome. METHODS: This retrospective cohort study included 30 patients with steroid-dependent nephrotic syndrome. Patients received regular single-dose rituximab (500 mg) intravenously every 6 months...
June 4, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38831156/analysis-of-the-impact-of-obesity-on-the-prognosis-of-iga-nephropathy-according-to-renal-function-and-sex
#38
JOURNAL ARTICLE
Yuki Ariyasu, Kazuo Torikoshi, Tatsuo Tsukamoto, Takashi Yasuda, Yoshinari Yasuda, Keiichi Matsuzaki, Keita Hirano, Tetsuya Kawamura, Takashi Yokoo, Shoichi Maruyama, Yusuke Suzuki, Eri Muso
BACKGROUND: Few studies have observed the direct effect of obesity on renal prognoses in immunoglobulin A nephropathy (IgAN) or separately evaluated its effects according to sex. We aimed to evaluate the direct and indirect effects of obesity on the renal outcomes of IgAN and observe these effects separately according to renal function and sex. METHODS: We extracted patients with body mass index (BMI) descriptions from a multicenter retrospective cohort analysis in Japan, and excluded those with < 30 days of follow-up, diabetes mellitus, and steroid treatment...
June 4, 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38396314/the-impact-of-low-and-high-dialysate-calcium-concentrations-on-cardiovascular-disease-and-death-in-patients-undergoing-maintenance-hemodialysis-a-systematic-review-and-meta-analysis
#39
JOURNAL ARTICLE
Keita Kamei, Shunsuke Yamada, Koji Hashimoto, Tsuneo Konta, Takayuki Hamano, Masafumi Fukagawa
BACKGROUND: The optimal dialysate calcium (Ca) concentration for patients undergoing hemodialysis remains inconclusive, particularly concerning cardiovascular protection. METHODS: We conducted a systematic review of 19 randomized controlled trials (RCTs) and a meta-analysis of eight RCTs to determine the optimal dialysate Ca concentration for cardiovascular protection. We compared outcomes in patients receiving maintenance hemodialysis treated with either a low-Ca dialysate (LCD) (1...
June 2024: Clinical and Experimental Nephrology
https://read.qxmd.com/read/38814420/differences-in-characteristics-and-risk-factors-for-acute-kidney-injury-between-elderly-and-very-elderly-patients-a-retrospective-review
#40
JOURNAL ARTICLE
Yutaka Hatakeyama, Taro Horino, Shigehiro Yasui, Yoshio Terada, Yoshiyasu Okuhara
BACKGROUND: Few epidemiologic studies on acute kidney injury (AKI) have focused on the older adult population. This study aimed to clarify the characteristics and risk factors for AKI in this population. METHODS: This retrospective observational study was performed with the clinical data of all outpatients and inpatients aged ≥ 65 years at the time of enrolment at Kochi Medical School Hospital between 1 January 1981 and 31 December 2021. The primary cohort was divided into those aged 65-74 and ≥ 75 years...
May 30, 2024: Clinical and Experimental Nephrology
journal
journal
32795
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.